Short answer
Pediatrix Medical Group, Inc. (MD) filed its Q1 2026 10-Q quarterly report on May 5, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $476M (up 3.9% year over year) with net income of $30M.
Q1 2026 key financials · XBRL
- Revenue
- $476M
- +3.9% YoY
- Net income
- $30M
- +42.6% YoY
- Operating margin
- 8.7%
- EPS (diluted)
- $0.36
- +50.0% YoY
Source: XBRL data from the Pediatrix Medical Group, Inc. (MD) Q1 2026 10-Q on SEC EDGAR. USD.
Pediatrix Medical Group, Inc. Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- No material changes to risk factors disclosed in the 2025 Form 10-K
- Share-repurchase exposure, with $103.7 million remaining under the August 2025 $250.0 million authorization
- Inflation Reduction Act compliance cost, including 1% excise tax on share repurchases
- Executive-transition risk, with General Counsel Mary Ann E. Moore departing before year-end 2026
- Repurchase timing risk tied to economic conditions, market conditions, and trading restrictions
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Pediatrix Medical Group, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.